Eventide Asset Management - Q1 2017 holdings

$1.51 Billion is the total value of Eventide Asset Management's 121 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 18.0% .

 Value Shares↓ Weighting
MIC BuyMACQUARIE INFRASTRUCTURE COR$58,155,000
-1.1%
721,700
+0.2%
3.85%
+0.6%
XPO  XPO LOGISTICS INC$54,116,000
+11.0%
1,130,0000.0%3.58%
+12.9%
BLUE SellBLUEBIRD BIO INC$51,786,000
+42.8%
569,700
-3.1%
3.43%
+45.3%
LOW  LOWES COS INC$46,449,000
+15.6%
565,0000.0%3.08%
+17.6%
LRCX SellLAM RESEARCH CORP$42,038,000
+20.7%
327,500
-0.6%
2.78%
+22.8%
KAR  KAR AUCTION SVCS INC$39,303,000
+2.5%
900,0000.0%2.60%
+4.2%
CELG  CELGENE CORP$37,988,000
+7.5%
305,3000.0%2.52%
+9.4%
ABBV SellABBVIE INC$36,183,000
-31.2%
555,300
-33.9%
2.40%
-30.1%
STLD  STEEL DYNAMICS INC$33,022,000
-2.3%
950,0000.0%2.19%
-0.6%
SGEN SellSEATTLE GENETICS INC$33,002,000
+11.7%
525,000
-6.2%
2.18%
+13.6%
SPLK  SPLUNK INC$31,145,000
+21.8%
500,0000.0%2.06%
+23.9%
WBC  WABCO HLDGS INC$30,013,000
+10.6%
255,6000.0%1.99%
+12.6%
CCI BuyCROWN CASTLE INTL CORP NEW$29,119,000
+9.6%
308,300
+0.7%
1.93%
+11.5%
W BuyWAYFAIR INCcl a$28,303,000
+130.7%
699,000
+99.7%
1.87%
+134.8%
CYBR  CYBERARK SOFTWARE LTD$27,979,000
+11.8%
550,0000.0%1.85%
+13.8%
IPHI SellINPHI CORP$27,095,000
-24.0%
555,000
-30.5%
1.79%
-22.7%
STKL BuySUNOPTA INC$27,015,000
-0.0%
3,887,000
+1.4%
1.79%
+1.7%
SNA  SNAP ON INC$26,987,000
-1.5%
160,0000.0%1.79%
+0.2%
ASML  ASML HOLDING N V$26,560,000
+18.4%
200,0000.0%1.76%
+20.4%
LEA SellLEAR CORP$26,051,000
-43.8%
184,000
-47.4%
1.72%
-42.8%
NEP SellNEXTERA ENERGY PARTNERS LP$25,990,000
+29.0%
784,500
-0.6%
1.72%
+31.3%
MGA SellMAGNA INTL INC$25,909,000
-19.4%
600,300
-18.9%
1.72%
-17.9%
IDTI  INTEGRATED DEVICE TECHNOLOGY$24,775,000
+0.5%
1,046,7000.0%1.64%
+2.2%
DOOR BuyMASONITE INTL CORP NEW$24,568,000
+23.9%
310,000
+2.9%
1.63%
+26.0%
LOXO SellLOXO ONCOLOGY INC$24,364,000
+2.5%
579,000
-21.8%
1.61%
+4.3%
PFPT SellPROOFPOINT INC$23,795,000
-12.5%
320,000
-16.9%
1.58%
-11.0%
CRUS SellCIRRUS LOGIC INC$22,455,000
-20.6%
370,000
-26.0%
1.49%
-19.1%
ROL  ROLLINS INC$21,907,000
+9.9%
590,0000.0%1.45%
+11.8%
FPRX SellFIVE PRIME THERAPEUTICS INC$21,726,000
-46.5%
601,000
-25.8%
1.44%
-45.6%
COLL BuyCOLLEGIUM PHARMACEUTICAL INC$21,665,000
-33.0%
2,153,612
+3.7%
1.43%
-31.9%
ARW  ARROW ELECTRS INC$21,656,000
+3.0%
295,0000.0%1.43%
+4.7%
AYI BuyACUITY BRANDS INC$20,604,000
-10.8%
101,000
+1.0%
1.36%
-9.2%
CAFD Sell8POINT3 ENERGY PARTNERS LPcl a rpt ltdpt$20,078,000
-0.4%
1,479,600
-4.8%
1.33%
+1.3%
VCYT SellVERACYTE INC$19,586,000
+12.4%
2,133,500
-5.3%
1.30%
+14.4%
AY BuyATLANTICA YIELD PLC$19,346,000
+11.7%
923,000
+3.1%
1.28%
+13.7%
TWLO NewTWILIO INCcl a$19,199,000665,000
+100.0%
1.27%
PEGI BuyPATTERN ENERGY GROUP INCcl a$17,916,000
+7.1%
890,000
+1.0%
1.19%
+8.9%
AGIO  AGIOS PHARMACEUTICALS INC$17,567,000
+40.0%
300,8000.0%1.16%
+42.4%
XLRN BuyACCELERON PHARMA INC$17,309,000
+58.1%
653,900
+52.5%
1.15%
+61.0%
INST  INSTRUCTURE INC$15,678,000
+19.7%
670,0000.0%1.04%
+21.8%
WCN  WASTE CONNECTIONS INC$15,439,000
+12.3%
175,0000.0%1.02%
+14.2%
HASI BuyHANNON ARMSTRONG SUST INFR C$14,221,000
+8.7%
704,000
+2.2%
0.94%
+10.6%
VMC NewVULCAN MATLS CO$13,253,000110,000
+100.0%
0.88%
WSO  WATSCO INC$12,886,000
-3.3%
90,0000.0%0.85%
-1.6%
WVE BuyWAVE LIFE SCIENCES LTD$11,921,000
+18.8%
433,500
+13.0%
0.79%
+20.8%
SUPN SellSUPERNUS PHARMACEUTICALS INC$11,581,000
+3.1%
370,000
-16.9%
0.77%
+4.9%
ACAD  ACADIA PHARMACEUTICALS INC$11,507,000
+19.2%
334,7000.0%0.76%
+21.3%
TSLA  TESLA INC$11,132,000
+30.2%
40,0000.0%0.74%
+32.6%
BPMC  BLUEPRINT MEDICINES CORP$10,597,000
+42.6%
265,0000.0%0.70%
+45.0%
AYR  AIRCASTLE LTD$10,342,000
+15.7%
428,6000.0%0.68%
+17.9%
KITE  KITE PHARMA INC$10,047,000
+75.0%
128,0000.0%0.66%
+78.3%
STML BuySTEMLINE THERAPEUTICS INC$9,289,000
+2.0%
1,086,400
+27.6%
0.62%
+3.7%
XNCR  XENCOR INC$8,228,000
-9.1%
344,0000.0%0.54%
-7.5%
ONCE  SPARK THERAPEUTICS INC$8,001,000
+6.9%
150,0000.0%0.53%
+8.8%
DBVT SellDBV TECHNOLOGIES S Asponsored adr$7,854,000
-10.4%
223,000
-10.7%
0.52%
-8.8%
GWPH  GW PHARMACEUTICALS PLCads$7,680,000
+8.2%
63,5000.0%0.51%
+10.0%
 ESSA PHARMA INC$7,411,000
+40.8%
2,719,4100.0%0.49%
+43.1%
PANW SellPALO ALTO NETWORKS INC$7,324,000
-44.2%
65,000
-38.1%
0.48%
-43.2%
ASND BuyASCENDIS PHARMA A Ssponsored adr$6,891,000
+48.7%
246,100
+7.5%
0.46%
+51.0%
AIMT NewAIMMUNE THERAPEUTICS INC$6,736,000310,000
+100.0%
0.45%
PRTA  PROTHENA CORP PLC$6,695,000
+13.4%
120,0000.0%0.44%
+15.4%
BMRN  BIOMARIN PHARMACEUTICAL INC$6,584,000
+6.0%
75,0000.0%0.44%
+7.9%
CERN  CERNER CORP$6,368,000
+24.3%
108,2000.0%0.42%
+26.7%
AVXS NewAVEXIS INC$6,158,00081,000
+100.0%
0.41%
GBT  GLOBAL BLOOD THERAPEUTICS IN$6,080,000
+155.0%
165,0000.0%0.40%
+160.0%
EXR  EXTRA SPACE STORAGE INC$6,063,000
-3.7%
81,5000.0%0.40%
-2.2%
RARE  ULTRAGENYX PHARMACEUTICAL IN$5,924,000
-3.6%
87,4000.0%0.39%
-2.0%
ATHN SellATHENAHEALTH INC$5,770,000
-72.7%
51,200
-74.6%
0.38%
-72.3%
SAGE SellSAGE THERAPEUTICS INC$5,757,000
-33.7%
81,000
-52.4%
0.38%
-32.6%
TTPH  TETRAPHASE PHARMACEUTICALS I$5,514,000
+128.0%
600,0000.0%0.36%
+132.5%
NBIX  NEUROCRINE BIOSCIENCES INC$5,413,000
+11.9%
125,0000.0%0.36%
+13.7%
INCY  INCYTE CORP$5,347,000
+33.3%
40,0000.0%0.35%
+35.6%
EPZM  EPIZYME INC$4,716,000
+41.7%
275,0000.0%0.31%
+43.8%
ALNY  ALNYLAM PHARMACEUTICALS INC$4,613,000
+36.9%
90,0000.0%0.30%
+39.3%
GLPG  GALAPAGOS NVspon adr$4,482,000
+34.3%
52,0000.0%0.30%
+36.9%
ACRS SellACLARIS THERAPEUTICS INC$4,175,000
-30.1%
140,000
-36.4%
0.28%
-28.9%
TSRO SellTESARO INC$4,001,000
-54.2%
26,000
-60.0%
0.26%
-53.4%
VYGR  VOYAGER THERAPEUTICS INC$3,972,000
+3.9%
300,0000.0%0.26%
+5.6%
RGEN  REPLIGEN CORP$3,872,000
+14.2%
110,0000.0%0.26%
+15.8%
BOLD  AUDENTES THERAPEUTICS INC$3,834,000
-6.7%
225,0000.0%0.25%
-4.9%
VRTX  VERTEX PHARMACEUTICALS INC$3,784,000
+48.5%
34,6000.0%0.25%
+51.2%
MYOV NewMYOVANT SCIENCES LTD$3,463,000295,000
+100.0%
0.23%
ATRC  ATRICURE INC$3,447,000
-2.2%
180,0000.0%0.23%
-0.4%
TCON BuyTRACON PHARMACEUTICALS INC$3,375,000
-20.4%
900,000
+4.0%
0.22%
-19.2%
CHRS  COHERUS BIOSCIENCES INC$3,067,000
-24.9%
145,0000.0%0.20%
-23.7%
NTUS  NATUS MEDICAL INC DEL$2,944,000
+12.8%
75,0000.0%0.20%
+14.7%
AQXP  AQUINOX PHARMACEUTICALS INC$2,921,000
+1.1%
175,0000.0%0.19%
+2.7%
MGNX SellMACROGENICS INC$2,734,000
-81.6%
147,000
-79.7%
0.18%
-81.2%
CTMX  CYTOMX THERAPEUTICS INC$2,591,000
+57.1%
150,0000.0%0.17%
+60.7%
ACHN NewACHILLION PHARMACEUTICALS IN$2,526,000600,000
+100.0%
0.17%
SYRS  SYROS PHARMACEUTICALS INC$2,390,000
+31.0%
150,0000.0%0.16%
+32.8%
CDTX  CIDARA THERAPEUTICS INC$2,059,000
-25.0%
264,0000.0%0.14%
-24.0%
JUNO  JUNO THERAPEUTICS INC$1,997,000
+17.7%
90,0000.0%0.13%
+20.0%
SEP BuySPECTRA ENERGY PARTNERS LP$1,659,000
+3.4%
38,000
+8.6%
0.11%
+5.8%
ALDR SellALDER BIOPHARMACEUTICALS INC$1,643,000
-63.3%
79,000
-63.3%
0.11%
-62.5%
BLCM SellBELLICUM PHARMACEUTICALS INC$1,604,000
-52.9%
130,000
-48.0%
0.11%
-52.3%
TIG  TIGENIXsponsored ads$1,560,000
+7.0%
100,0000.0%0.10%
+8.4%
HTGC SellHERCULES CAPITAL INC$1,513,000
+1.1%
100,000
-5.7%
0.10%
+3.1%
ARAY  ACCURAY INC$1,454,000
+3.2%
306,2000.0%0.10%
+4.3%
TSM BuyTAIWAN SEMICONDUCTOR MFG LTDsponsored adr$1,412,000
+27.6%
43,000
+11.7%
0.09%
+29.2%
BEP SellBROOKFIELD RENEWABLE PARTNERpartnership unit$1,323,000
-6.2%
44,500
-6.3%
0.09%
-4.3%
DRNA  DICERNA PHARMACEUTICALS INC$1,282,000
+18.0%
377,0000.0%0.08%
+19.7%
AGTC SellAPPLIED GENETIC TECHNOL CORP$1,270,000
-51.3%
184,100
-34.0%
0.08%
-50.6%
NYLD BuyNRG YIELD INCcl c$1,239,000
+20.6%
70,000
+7.7%
0.08%
+22.4%
JCI SellJOHNSON CTLS INTL PLC$1,243,000
+1.3%
29,500
-1.0%
0.08%
+2.5%
ABB BuyABB LTDsponsored adr$1,182,000
+32.1%
50,500
+18.8%
0.08%
+34.5%
BDN SellBRANDYWINE RLTY TRsh ben int new$982,000
-4.1%
60,500
-2.4%
0.06%
-3.0%
HMC SellHONDA MOTOR LTD$908,000
-14.7%
30,000
-17.8%
0.06%
-13.0%
PTI SellPROTEOSTASIS THERAPEUTICS IN$845,000
-68.7%
108,000
-50.9%
0.06%
-68.0%
KALV NewKALVISTA PHARMACEUTICALS INC$766,00098,100
+100.0%
0.05%
FHB BuyFIRST HAWAIIAN INC$718,000
+79.5%
24,000
+108.7%
0.05%
+84.6%
BG BuyBUNGE LIMITED$674,000
+21.2%
8,500
+10.4%
0.04%
+25.0%
GLBL BuyTERRAFORM GLOBAL INCcl a$600,000
+171.5%
125,000
+123.2%
0.04%
+185.7%
WBK BuyWESTPAC BKG CORPsponsored adr$548,000
+41.6%
20,500
+24.2%
0.04%
+44.0%
ETN  EATON CORP PLC$482,000
+10.6%
6,5000.0%0.03%
+14.3%
LPT SellLIBERTY PPTY TRsh ben int$463,000
-9.2%
12,000
-7.0%
0.03%
-6.1%
VTR BuyVENTAS INC$455,000
+21.3%
7,000
+16.7%
0.03%
+25.0%
ERIC BuyERICSSONadr b sek 10$392,000
+40.0%
59,000
+22.9%
0.03%
+44.4%
WELL BuyWELLTOWER INC$390,000
+16.4%
5,500
+10.0%
0.03%
+18.2%
LXP SellLEXINGTON REALTY TRUST$384,000
-13.3%
38,500
-6.1%
0.02%
-13.8%
TERP NewTERRAFORM PWR INC$136,00011,000
+100.0%
0.01%
ZSAN ExitZOSANO PHARMA CORP$0-272,000
-100.0%
-0.01%
NSC ExitNORFOLK SOUTHERN CORP$0-2,700
-100.0%
-0.02%
BBN ExitBLACKROCK TAX MUNICPAL BD TR$0-14,000
-100.0%
-0.02%
BIP ExitBROOKFIELD INFRAST PARTNERSlp int unit$0-11,462
-100.0%
-0.02%
TNDM ExitTANDEM DIABETES CARE INC$0-275,000
-100.0%
-0.04%
APU ExitAMERIGAS PARTNERS L Punit l p int$0-12,900
-100.0%
-0.04%
CPPL ExitCOLUMBIA PIPELINE PARTNERS L$0-45,000
-100.0%
-0.05%
OMED ExitONCOMED PHARMACEUTICALS INC$0-190,000
-100.0%
-0.10%
NVAX ExitNOVAVAX INC$0-1,449,700
-100.0%
-0.12%
TGTX ExitTG THERAPEUTICS INC$0-537,600
-100.0%
-0.16%
HRTX ExitHERON THERAPEUTICS INC$0-225,000
-100.0%
-0.19%
CSLT ExitCASTLIGHT HEALTH INCcl b$0-1,170,000
-100.0%
-0.38%
WAB ExitWABTEC CORP$0-160,000
-100.0%
-0.86%
BWA ExitBORGWARNER INC$0-440,000
-100.0%
-1.13%
MBBYF ExitMOBILEYE N V AMSTELVEEN$0-873,800
-100.0%
-2.17%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-05-15
Signatures

The EDGAR filing(s) were signed by:

About Eventide Asset Management

Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.

The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.

The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.

Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.

Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LOWES COS INC40Q3 20233.2%
PALO ALTO NETWORKS INC40Q3 20233.6%
ASML HOLDINGS NV40Q3 20231.9%
NEUROCRINE BIOSCIENCES INC40Q3 20231.1%
REPLIGEN CORP40Q3 20230.5%
VERACYTE INC38Q3 20231.5%
LAM RESEARCH CORP35Q3 20233.4%
XPO LOGISTICS INC34Q1 20233.8%
COLLEGIUM PHARMACEUTICAL INC34Q3 20232.6%
MAGNA INTL INC33Q4 20212.5%

View Eventide Asset Management's complete holdings history.

Latest significant ownerships (13-D/G)
Eventide Asset Management Q1 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cogent Biosciences, Inc.February 14, 20232,589,7783.7%
ESSA Pharma Inc.Sold outFebruary 14, 202300.0%
Freeline Therapeutics Holdings plcFebruary 14, 20235,920,7659.1%
KnowBe4, Inc.Sold outFebruary 14, 202300.0%
Praxis Precision Medicines, Inc.February 14, 20233,518,0627.5%
Prometheus Biosciences, Inc.February 14, 20231,032,9382.2%
SUTRO BIOPHARMA, INC.Sold outFebruary 14, 202300.0%
Vital Farms, Inc.Sold outFebruary 14, 202300.0%
Zymeworks Inc.Sold outFebruary 14, 202300.0%
Entasis Therapeutics Holdings Inc.February 14, 2022590,6021.2%

View Eventide Asset Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Eventide Asset Management's complete filings history.

Compare quarters

Export Eventide Asset Management's holdings